Hereditary optic neuropathies

Eye

Volumn 18, Issue 11, 2004, Pages 1144-1160

  Newman, N J ^a,b   Biousse, V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

Autosomal dominant optic atrophy; Hereditary optic neuropathy; Kjer's disease; Leber's hereditary optic neuropathy; Mitochondrial disease; Optic atrophy; Visual loss

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARNITINE; DICHLOROACETIC ACID; IDEBENONE; MENADIONE; NUCLEOTIDE; PARVOVIRUS VECTOR; PHYTOMENADIONE; RIBOFLAVIN; SUCCINIC ACID; THIAMINE; UBIDECARENONE;

AUTOSOMAL DOMINANT OPTIC ATROPHY; CLINICAL FEATURE; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MEDICAL LITERATURE; NONHUMAN; OPTIC NERVE DISEASE; PHENOTYPE; RETROSPECTIVE STUDY; REVIEW;

EID: 9944238788     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701591     Document Type: Review

References (190)

1. Newman NJ. Hereditary optic neuropathies. In: Miller NR, Newman NJ (eds). Walsh & Hoyt Clinical Neuro-Ophthalmology, Vol. 1, 5th edn. Williams & Wilkins: Baltimore, 1999 pp 741-773.
2. Biousse V, Newman NJ. Hereditary optic neuropathies. Ophthalmol Clin NA 2001; 14: 547-568.
3. Leber T. Über hereditare und congenitalangelegte sehnervenleiden. Albrecht von Graefe's Arch Ophthalmol 1871; 17 249-291.
4. von Graefe A. Ein ungewohnlicher fall von hereditare amaurose. Arch Ophthalmol 1858; 4: 266-268.
5. Asseman R. La Maladie de Leber Etude Clinique et Genetique à Propos de 86 Cas Examines. Thèse, Universitaire de Lille, 1958.
6. Van Senus AHC. Leber's disease in the Netherlands. Doc Ophthalmol 1963; 17: 1-163.
7. Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991; 111: 750-762.
8. Mackey D, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol 1992; 20: 177-184.
9. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MC, DaCosta J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-337.
10. Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y et al. Clinical features of Japanese Leber's hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol 1995; 39: 96-108.
11. Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996; 103: 504-514.
12. Yamada K, Oguchi Y, Hotta Y, Nakamura M, Isashiki Y, Mashima Y. Multicenter study on the frequency of three primary mutations of mitochondrial DNA in Japanese pedigrees with Leber's hereditary optic neuropathy: comparison with American and British counterparts. Neuro-ophthalmology 1999; 22: 187-193.
13. Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros P, Sadun F et al. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc 2002; 100 169-180.
14. Yen M-Y, Wang A-G, Chang W-L, Hsu W-M, Liu J-H, Wei Y-H. Leber's hereditary optic neuropathy-the spectrum of mitochondrial DNA mutations in Chinese patients. Jpn J Ophthalmol 2002; 46: 45-51.
15. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-1430.
16. Newman NJ. Leber's hereditary optic neuropathy: new genetic considerations. Arch Neurol 1993; 50: 540-548.
17. Mackey DA, Oostra R-J, Rosenberg T, Nikoskelainen E, Bronte-Stewart J, Poulton J et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. (Letter). Am J Hum Genet 1996; 59: 481-485.
18. Chinnery PF, Brown DT, Andrews RM, Singh-Kler R, Riordan-Eva P, Lindley J et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. Brain 2001; 124: 209-218.
19. Huoponen, K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001; 3: 119-125.
20. Man PYW, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet 2002; 39: 162-169.
21. Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48: 188-193.
22. Man PYW, Griffiths PG, Brown DT. The epidemiology of Leber hereditary optic neuropathy in the north east of England. Am J Hum Genet 2003; 72: 333-339.
23. Mackey DA. Epidemiology of Leber's hereditary optic neuropathy in Australia. Clin Neurosci 1994; 2: 162-164.
24. Mackey DA. Three subgroups of patients from the United Kingdom with Leber hereditary optic neuropathy. Eye 1994; 8: 431-436.
25. Chan C, Mackey DA, Byrne E. Sporadic Leber hereditary optic neuropathy in Australia and New Zealand. Aust N Z J Ophthalmol 1996; 24: 7-14.
26. Nikoskelainen EK, Savontaus ML, Wanne OP, Katila MJ, Nummelin KU. Leber's hereditary optic neuroretinopathy, a maternally inherited disease. A genealogic study in four pedigrees. Arch Ophthalmol 1987; 105: 665-671.
27. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995; 57: 77-86.
28. Mackey D, Howell N. Tobacco amblyopia [Letter]. Am J Ophthalmol 1994; 117: 817-818.
29. Carroll WM, Mastaglia FL. Leber's optic neuropathy. A clinical and visual evoked potential study of affected and asymptomatic members of a six generation family. Brain 1979; 102: 559-580.
30. Wakakura M, Yokoe J. Evidence for preserved direct pupillary light response in Leber's hereditary optic neuropathy. Br J Ophthalmol 1995; 79: 442-446.
31. Jacobson DM, Stone EM, Miller NR, Pollock SC, Fletcher WA, McNussen PJ et al. Relative afferent papillary defects in patients with Leber hereditary optic neuropathy and unilateral visual loss. Am J Ophthalmol 1998; 126: 291-295.
32. Raaf JE, Bair HL. Leber's disease: report of four cases in one family. Am J Ophthalmol 1938; 21: 384-389.
33. Weiner NC, Newman NJ, Lessell S, Johns DR, Lott MT, Wallace DC. Atypical Leber's hereditary optic neuropathy with molecular confirmation. Arch Neurol 1993; 50: 470-473.
34. Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol 1973; 90: 349-354.
35. Stone EM, Newman NJ, Miller NR, Johns DR, Lott MT, Wallace DC. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuro - Ophthalmol 1992; 12: 10-14.
36. Brunette JR, Bernier G. Study of a family of Leber's optic atrophy with recuperation. In: Brunette JR, Barbeau A (eds). Progress in Neuro-Ophthalmology. Excerpta Medica: Amsterdam, 1969 pp 91-97.
37. Nikoskelainen E, Wanne O, Dahl M. Pre-excitation syndrome and Leber's hereditary optic neuroretinopathy. Lancet 1985; 1: 696.
38. Ortiz RG, Newman NJ, Manoukian S, Diesenhouse MC, Lott MT, Wallace DC. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber's hereditary optic neuropathy. Am J Ophthalmol 1992; 113: 561-566.
39. Nikoskelainen EK, Savontaus ML, Huoponen J, Antila K, Hartiala J. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Lancet 1994; 344: 857-858.
40. Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy. Clin Genet 1996; 50: 535-537.
41. Finsterer J, Stollberger C, Kopsa W, Jaksch M. Wolff-Parkinson-White syndrome and isolated left ventricular abnormal trabeculation as a manifestation of Leber's hereditary optic neuropathy. Can J Cardiol 2001; 17: 464-466.
42. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P et al. Leber's 'plus': neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995; 59: 160-164.
43. Chalmers RM, Harding AE. A case-control study of Leber's hereditary optic neuropathy. Brain 1996; 119: 1481-1486.
44. Wallace DC. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain 1970; 93: 121-132.
45. Novotny EJ, Singh G, Wallace DC, Dorfman LJ, Louis A, Sogg RL. Leber's disease and dystonia. A mitochondrial disease. Neurology 1986; 36: 1053-1060.
46. Marsden DC, Lang AE, Quinn NP, McDonald WI, Abdallat A, Nimri S. Familial dystonia and visual failure with striatal CT lucencies. J Neurol Neurosurg Psychiatry 1986; 49: 500-509.
47. Bruyn GW, Vielvoye GJ, Went LN. Hereditary spastic dystonia: a new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign. J Neurol Sci 1991; 103: 195-202.
48. Leuzzi V, Bertini E, De Negri AM, Gallucci M, Garavaglia B. Bilateral striatal necrosis, dystonia and optic atrophy in two siblings. J Neurol Neurosurg Psychiatry 1992; 55: 16-19.
49. De Vries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RM, Bolhuis PA et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996; 58: 703-711.
50. Hanemann CO, Hefter H, Schlaug G, Seitz RJ, Freund HJ, Benecke R. Characterization of basal ganglia dysfunction in Leber 'plus' disease. J Neurol 1996; 243: 297-300.
51. Riggs JE, Ellis BD, Hogg JP, Al-Azzaz A, Schochet Jr SS. Acute periaqueductal syndrome associated with the G11778A mitochondrial DNA mutation. Neurology 2001; 56: 570-571.
52. Sadler M, Wiles CM, Stoodley N, Linnane SJ, Smith AP. Ondine's curse in a woman with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2002; 73: 347-348.
53. Funalot B, Reynier P, Vighetto A, Ranoux D, Bonnefont J-P, Godinot C et al. Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Ann Neurol 2002; 52: 374-377.
54. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D et al. Occurrance of a multiple sclerosis-like illness in women who have a Leber's hereditary optic Neuropathy Mitochondrial DNA mutation. Brain 1992; 115: 979-989.
55. Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuro-ophthalmol 1999; 19: 28-33.
56. Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994; 36: 109-112.
57. Leuzzi V, Carducci C, Lanza M, Salvetti M, Ristori G, DiGiovanni S et al. LHON mutations in Italian patients affected by multiple sclerosis. Acta Neurol Scand 1997; 96: 145-148.
58. Wakakura M, Mogi A, Ichibe Y, Okada K, Hasebe H. Leber's hereditary optic neuropathy triggered by optic neuritis. Neuro-ophthalmology 1996; 16: 337-341.
59. Kermode AG, Moseley IF, Kendall BE, Miller DH, MacManus DG, McDonald WI. Magnetic resonance imaging in Leber's optic neuropathy. J Neurol Neurosurg Psychiatry 1989; 52: 671-674.
60. Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002; 6: 121-123.
61. Smith JL, Tse DT, Byrne SF, Johns DR, Stone EM. Optic nerve sheath distention in Leber's optic neuropathy and the significance of the 'Wallace mutation'. J Clin Neuro-Ophthalmol 1990; 10: 231-238.
62. Wilson DR, Kline LB. Leber's hereditary optic neuropathy with bilateral distended optic nerve sheaths. J Clin Neuro-Ophthalmol 1992; 12: 73-74.
63. Dotti MT, Caputo N, Signorini E, Federico A. Magnetic resonance imaging findings in Leber's hereditary optic neuropathy. Eur Neurol 1992; 32: 17-19.
64. Mashima Y, Oshitari K, Imamura Y, Momoshima S, Shiga H, Oguchi Y. Orbital high resolution magnetic resonance imaging with fast spin echo in the acute stage of Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1998; 64: 124-127.
65. Inglese M, Rovaris M, Bianchi S, LaMantia L, Mancardi GL, Ghezzi A et al. Magnetic resonance imaging, magnetization transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001; 70: 444-449.
66. Vaphiades MS, Newman NJ. Optic nerve enhancement on orbital magnetic resonance imaging in Leber's hereditary optic neuropathy. J Neuro-ophthalmol 1999; 19: 238-239.
67. Vaphiades MS, Phillips PH, Turbin RE. Optic nerve and chiasmal enhancement in Leber hereditary optic neuropathy. J Neuro-ophthalmol 2003; 23: 104-105.
68. Phillips PH, Vaphiades M, Glasier CM, Gray LG, Lee AG. Chiasmal enlargement and optic nerve enhancement on magnetic resonance imaging in Leber hereditary optic neuropathy. Arch Ophthalmol 2003; 121: 577-579.
69. Kerrison JB, Howell N, Miller NR, Hirst L, Green WR. Leber hereditary optic neuropathy: electron microscopy and molecular genetic analysis of a case. Ophthalmology 1995; 102: 1509-1516.
70. Saadati HG, Hsu HY, Heller KB, Sadun AA. A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy. Arch Ophthalmol 1998; 116: 911-916.
71. Sadun AA, Win P, Ross-Cisneros F, Walker S, Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000; 98: 1-13.
72. Newman NJ. From genotype to phenotype in Leber hereditary optic neuropathy: still more questions than answers. J Neuro-ophthalmol 2002; 22: 257-261.
73. Macmillan C, Johns TA, Fu K, Shoubridge EA. Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect. Am J Hum Genet 2000; 66: 332-335.
74. Carelli V, Rengo C, Scozzari R, Valentino ML, Carrara F, Zeviani M et al. mtDNA haplotypes allow genealogical aggregation of apparently unrelated LHON pedigrees. Neurology 2003; 60 Suppl): A3.
75. Biousse V, Brown MD, Newman NJ, Allen JC, Rosenfeld J, Meola G et al. De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber's hereditary optic neuropathy. Neurology 1997; 49: 1136-1138.
76. Chinnery PF, Andrews RM, Turnbull DM, Howell N. Leber hereditary optic neuropathy: does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? Am J Med Genet 2001; 98: 235-243.
77. Oostra RJ, Bolhuis PA, Wijburg FA, Zorn-Ende G, Bleeker-Wagemakers EM. Leber's hereditary optic neuxopathy. Correlations between mitochondrial genotype and visual outcome. J Med Genet 1994; 31: 280-286.
78. Brown MD, Allen JC, VanStavern GP, Newman NJ, Wallace DC. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 2001; 104: 331-338.
79. Howell N, Miller NR, Mackey DA, Arnold A, Hermstadt C, Williams IM et al. Lightning strikes twice: Leber hereditary optic neuropathy families with two pathogenic mtDNA mutations. J Neuro-ophthalmol 2002; 22: 262-269.
80. Brown MD, Starikovskaya E, Derbeneva O, Hosseini S, Allen JC, Mikhailovskaya IE et al. The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup. J Hum Genet 2002; 110: 130-138.
81. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitrochondrial respiratory chain function: possible factor in aging. Lancet 1989; 1: 637-639.
82. Newman NJ, Torroni A, Brown MD, Lott MT, Fernandez MM, Wallace DC. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's hereditary optic neuropathy patients. Am J Ophthalmol 1994; 118: 158-168.
83. Kerrison JB, Miller NR, Hsu F-C, Beaty TH, Maumenee IH, Smith KH et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol 2000; 130 803-812.
84. Dotti MT, Plewnia K, Cardaioli E, Manneschi L, Rufa A, Alema G et al. A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778. J Neurol 1998; 245: 302-303.
85. DeMarinis M. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation. J Neurol 2001; 248: 818-819.
86. Luzhansky JZ, Pierce AB, Hoy JF, Hall AJ, Anthony JH. Leber's hereditary optic neuropathy in the setting of nucleoside analogue toxicity. AIDS 2001; 15: 1588-1589.
87. Shaikh S, Ta C, Basham AA, Mansour S. Leber hereditary optic neuropathy associated with antiretroviral therapy for human immunodeficiency virus infection. Am J Ophthalmol 2001; 131: 143-145.
88. Warner JE, Ries KM. Optic neuropathy in a patient with AIDS. J Neuro-ophthalmol 2001; 21: 92-94.
89. Howell N. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vision Res 1998; 38: 1495-1504.
90. Schapira AH. Mitochondrial disorders: an overview. J Bioenergetics Biomemb 1997; 29: 105-107.
91. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenergetics Biomembranes 1997; 29: 131-149.
92. Qi X, Lewin AS, Hauswirth WK, Guy J. Suppression of complex I gene expression induces optic neuropathy. Ann Neurol 2003; 53 198-205.
93. Imachi J. Neuro-surgical treatment of Leber's optic atrophy and its pathogenetic relationship to arachnoiditis. In: Brunette JR, Barbeau A (eds). Progress in Ophthalmology (Proceedings of the Second International Congress of Neuro-Genetics and Neuro-Ophthalmology), Vol. 2. Excerpta Medica: Amsterdam, 1967 p 121.
94. Imachi J, Nishizaki K. The patients of Leber's optic atrophy should be treated neuro-surgically. Nippon Ganka Kiyo Jpn 1970; 21: 209-217.
95. Geromel V, Darin N, Chretien D, Benit P, DeLonlay P, Rotig A et al. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab 2002; 77: 21.
96. Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenon and vitamin therapy shorten the time to achieve visual recover in Leber hereditary optic neuropathy? J Neuro-ophthalmol 2000; 20: 166-170.
97. Yoles E, Wheeler LA, Schwartz M. Alpha-2-adenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 1999; 40: 65-73.
98. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V et al. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol 2002; 52: 534-542.
99. Larsson NG. Leber's hereditary optic neuropathy: a nuclear solution of a mitochondrial problem. Ann Neurol 2002; 52: 529-530.
100. Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis. Hum Mol Genet 1994; 3: 977-980.
101. Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthal Scand 1996; 74: 3-7.
102. Kjer P. Infantile optic atrophy with dominant mode of inheritance. A clinical and genetic study of 19 Danish families. Acta Ophthalmol 1959; 37(suppl. 54).
103. Kjer P. Hereditary infantile optic atrophy with dominant transmission (preliminary report). Dan Med Bull 1956; 3: 135-141.
104. Smith DP. Diagnostic criteria in dominantly inherited juvenile optic atrophy: a report of three new families. Am J Optom Physiol Opt 1972; 49: 183-200.
105. Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol 1979; 88: 868-875.
106. Kline LB, Glaser JS. Dominant optic atrophy: The clinical profile. Arch Ophthalmol 1979; 97: 1680-1686.
107. Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology 1980; 87: 245-251.
108. Elliott D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol 1993; 115: 360-367.
109. Brown Jr J, Fingert J, Taylor CM, Lake M, Sheffield VC, Stone EM. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1). Arch Ophthalmol 1997; 115: 95-99.
110. Johnston RL, Burdon MA, Spalton DJ, Bryant SP, Behnam JT, Seller MJ. Dominant optic atrophy, Kjer type. Arch Ophthalmol 1997; 115: 100-103.
111. Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998; 116: 351-358.
112. Kerrison JB, Arnould VJ, Ferraz Sallum JM, Vagefi MR, Barmada MM, Li Y et al. Genetic heterogeneity of dominant optic atrophy, Kjer type. Arch Ophthalmol 1999; 117: 805-810.
113. Johnston RL, Seller MJ, Behnam JT, Burdon MA, Spalton DJ. Dominant optic atrophy. Refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology 1999; 106: 123-128.
114. Smith DP. The assessment of acquired dyschromatopsia and clinical investigation of the acquired tritan defect in dominantly inherited juvenile atrophy. Am J Optom Physiol Opt 1972; 49: 574-588.
115. Votruba M, Thiselton D, Battacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol 2003; 87: 48-53.
116. Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy. Differentiation from normal tension glaucoma. Ophthalmology 2001; 108: 1595-1602.
117. Harding GFA, Crews SJ, Pitts SM. Psychophysical and visual evoked potential findings in hereditary optic atrophy. Trans Ophthalmol Soc UK 1979; 99: 96-102.
118. Del Porto G, Vingolo EM, Steindl K, Forte R, Iannaccone A, Rispoli E et al. Clinical heterogeneity of dominant optic atrophy: the contribution of visual function investigations to diagnosis. Graefe's Arch Clin Exp Ophthalmol 1994; 32: 717-727.
119. Kivlin JD, Lovrien EW, Bishop DT, Maumenee IH. Linkage analysis in dominant optic atrophy. Am J Hum Genet 1983; 35: 1190-1195.
120. Lunkes A, Hartung AU, Magarino C, Rodriguez M, Palmero A, Rodriguez L et al. Refinement of the OPAI gene locus on chromosome 3q28-q29 to a region of 2-8 cM, in one Cuban pedigree with autosomal dominant optic atrophy type Kjer. Am J Hum Genet 1995; 57: 968-970.
121. Jonasdottir A, Eiberg H, Kjer B, Kjer P, Rosenberg T. Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig. Hum Genet 1997; 99: 115-120.
122. Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nature Genet 2000; 26: 207-210.
123. Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nature Genet 2000; 26: 211-215.
124. Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 2002; 75: 97-107.
125. Shimizu S, Mori N, Kishi M, Sugata H, Tsuda A, Kubota N. A novel mutation in the OPA1Gene in a Japanese patient with optic atrophy. Am J Ophthalmol 2003; 135: 256-257.
126. Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 2001; 10: 1359-1368.
127. Toomes C, Marchbank NJ, Mackey DA, Craig JE, Newbury-Ecob RA, Bennett CP et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet 2001; 10: 1369-1378.
128. Marchbank NJ, Craig JE, Leek JP, Toohey M, Churchill AJ, Markham AF et al. Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease. J Med Genet 2002; 39: e47.
129. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003; 278: 7743-7746.
130. Aung T, Okada K, Poinoosawmy D, Membrey L, Brice G, Child AH et al. The phenotype of normal tension glaucoma patients with and without OPA1 polymorphisms. Br J Ophthalmol 2003; 87: 49-152.
131. Rice DS, Williams RW, Ward-Bailey P, Johnson KR, Harris BS, Davisson MT et al. Mapping the Bst mutation on mouse chromosome 16: a model for human optic atrophy. Mamm Genome 1995; 6: 546-548.
132. Waardenburg PJ. Different types of hereditary optic atrophy. Acta Genet Statist Med 1957; 7: 287-290.
133. Went LN, De Vries-De Mol EC, Voklker-Dieben HJ. A family with apparently sex-linked optic atrophy. J Med Genet 1975; 12: 94-98.
134. Assink JJM, Tijmes NT, ten Brink JB, Oostra R-J, Riemslag FC, deJong PTVM et al. A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet 1997; 61: 934-939.
135. Pomeranz; HD, Lessell S. A hereditary chiasmal optic neuropathy. Arch Ophthalmol 1999; 117: 128-131.
136. Wolfram DJ. Diabetes mellitus and simple optic atrophy among siblings. Mayo Clin Proc 1938; 13: 715-717.
137. Lessell S, Rosman NP. Juvenile diabetes mellitus and optic atrophy. Arch Neurol 1977; 34: 759-765.
138. Dreyer M, Rudiger HW, Bujara K, Herberhold C, Kuhnau J, Maack P et al. The syndrome of diabetes insipidus, diabetes mellitus optic atrophy, deafness, and other abnormalities (DIDMOAD-syndrome). Two affected sibs and a short review of the literature (98 cases). Klin Wochenschr 1982; 60: 471-475.
139. Barrett TG, Bundley SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346: 1458-1463.
140. Scolding NJ, Kellar-Wood HF, Shaw C, Shneerson JM, Antoun N. Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 1996; 9: 352-360.
141. Barrett TG, Bundey SE, Fielder AR, Good PA. Optic atrophy in Wolfram (DIDMOAD) syndrome. Eye 1997; 11: 882-888.
142. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997; 34: 838-841.
143. Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol 2002; 12: 84-88.
144. Simsek E, Simsek T, Tekgul S, Hosal S, Seyrantepe V, Aktan G. Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature. Acta Paediatr 2002; 92: 55-61.
145. Castro FJ, Barrio J, Perena MF, Palomar MT, Cristobal JA. Uncommon ophthalmologic findings associated with Wolfram syndrome. Acta Ophthalmol Scand 2000; 78: 118-119.
146. Swift RG, Perkins DO, Chase CL, Sadler DB, Swift M. Psychiatric disorders in 36 families with Wolfram syndrome. Am J Psychiatry 1991; 148: 775-779.
147. Rando TA, Horton JC, Layzer RB. Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology 1992; 42: 1220-1224.
148. Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care 1995; 18: 1566-1570.
149. Borgna-Pignatti C, Marradi P, Pinelli L, Monetti N, Patrini C. Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr 1989; 114: 405-410.
150. Biousse V, Newman NJ. Neuro-ophthalmology of mitochondrial disorders. Curr Opin Neurol 2003; 16: 35-43.
151. Bundey S, Pulton K, Whitwell H, Curtis E, Brown IAR, Fielder AR. Mitochondrial abnormalities in the DIDMOAD syndrome. J Inherited Metab Dis 1992; 15: 315-319.
152. Barrientos A, Casademont J, Saiz A, Cardellach F, Volpini V, Solans A et al. Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet 1996; 58 963-970.
153. Polymeropoulos MH, Swift RG, Swift M. Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nature Genet 1994; 8: 95.
154. Collier DA, Barrett TG, Curtis D, Macleod A, Arranz MJ, Maassen JA et al. Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet 1996; 59: 855-863.
155. Van Den Ouweland JM, Cryns K, Pennings RJ, Walraven I, Janssen GM, Maassen JA et al. Molecular characterization of WFS1 in patients with Wolfram syndrome. J Mol Diagn 2003; 5: 88-95.
156. Cryns K, Pfister M, Pennings RJ, Bom SJ, Flothmann K, Caethoven G et al. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet 2002; 110: 389-394.
157. Barrientos A, Volpini V, Casademont J, Genís D, Nanzanares J-M, Ferrer I et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest 1996; 97: 1570-1576.
158. Hofmann S, Bezold R, Jaksch M, Obermaier-Kusser B, Mertens S, Kaufhold P et al. Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitrochondrial DNA haplotypes. Genomics 1997; 39: 8-18.
159. Ajlouni K, Jarrah N, El-Khateeb M, El-Zaheri M, El Shanti H, Lidral A. Wolfram syndrome: identification of a phenotypic and genotypic variant from Jordan. Am J Med Genet 2002; 115: 61-65.
160. Behr C. Die komplizierte, hereditar-familare optikusatrophie des kindesalters: ein bisher nicht beschriebener symptomkomplex. Klin Montasbl Augenheilkd 1909; 47: 138-160.
161. Francois J. Mode d'heredite des heredo-degenerescences du nerf optique. J Genet Hum 1966; 15: 147-220.
162. Francois J. Les atrophies optiques hereditaires. J Genet Hum 1976; 24: 183-200.
163. Costeff H, Gadoth N, Apter N, Prialnic M, Savir H. A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology 1989; 39: 595-597.
164. Sheffer RN, Zlotogora J, Elpeleg ON, Raz J, Ben-Ezra D. Behr's syndrome and 3-methylglutaconic aciduria. Am J Ophthalmol 1992; 114: 494-497.
165. Costeff H, Elpeleg O, Apter N, Divry P, Gadoth N. 3-Methylglutaconic aciduria in 'optic atrophy plus. Ann Neurol 1993; 33: 103-104.
166. Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet 2001; 69: 1218-1224.
167. Lynch DR, Farmer J. Practical approaches to neurogenetic disease. J Neuro-ophthalmol 2002; 22: 297-304.
168. Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C et al. Clinical description roentgenologicevaluation of patients with Friedreich's ataxia. Can J Neurol Sci 1976; 3: 279-286.
169. Carroll WM, Kriss A, Baraitser M, Barrett G, Halliday AM. The incidence and nature of visual pathway involvement in Friedreich's ataxia: a clinical and visual evoked potential study of 22 patients. Brain 1980; 103: 413-434.
170. Livingstone IR, Mastaglia FL, Edis R, Howe JW. Visual involvement in Friedreich's ataxia and hereditary spastic ataxia: a clinical and visual evoked response study. Arch Neurol 1981; 38 75-79.
171. Wenzel W, Camacho L, Claus D, Aschoff J. Visually evoked potentials in Friedreich's ataxia. Adv Neurol 1982; 32: 131-139.
172. Müller-Felber W, Rossmanith T, Spes C, Chamberlain S, Pongratz D, Deufel T. The clinical spectrum of Friedreich's ataxia in German families showing linkage to the FRDA locus on chromosome 9. Clin Invest 1993; 71: 109-114.
173. Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 1997; 41: 675-682.
174. Givre SJ, Wall M, Kardon RH. Visual loss and recovery in a patient with Friedreich ataxia. J Neuro-ophthalmology 2000; 20 229-233.
175. Belal S, Hentati F, Ben Hamida C, Ben Hamida M. Friedreich's ataxia-vitamin E responsive type. The chromosome 8 locus. Clin Neurosci 1995; 3: 39-42.
176. Klockgether T, Wullner U, Spauschus A, Evert B. The molecular biology of the autosomal-dominant cerebellar ataxias. Mov Disord 2000; 15: 604-612.
177. Abe T, Abe K, Aoki M, Itoyama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997; 115: 231-236.
178. Harding AE. The clinical features and classification of late onset autosomal dominant cerebellar ataxias: A study of 11 families, including descendants of the 'Drew family of Walworth. Brain 1982; 105: 1-28.
179. Durr A, Brice A, Lepage-Lezin A, Cancel G, Smadja D, Vernant JC et al. Autosomal dominant cerebellar ataxia type I linked to chromosome 12q (SCA2: spinocerebellar ataxia type 2). Clin Neurosci 1995; 3: 12-16.
180. Kuhlenbaumer G, Young P, Hunermund G, Ringelstein B, Stogbauer F. Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol 2002; 249: 1629-1650.
181. Chalmers RM, Bird AC, Harding AE. Autosomal dominant optic atrophy with asymptomatic peripheral neuropathy. J Neurol Neurosurg Psychiatry 1996; 60: 195-196.
182. Chalmers RM, Riordan-Eva P, Wood NW. Autosomal recessive inheritance of hereditary motor and sensory neuropathy with optic atrophy. J Neurol Neurosurg Psychiatry 1997; 62: 385-387.
183. Gadoth N, Gordon CR, Bleich N, Pratt H. Three modality evoked potentials in Charcot-Marie-Tooth Disease (HMSN-1). Brain Dev 1991; 13: 91-94.
184. Rizzo JF (III, Lessell S, Liebman SD. Optic atrophy in familial dysautonomia. Am J Ophthalmol 1986; 102: 463-467.
185. Groom M, Kay MD, Corrent GF. Optic neuropathy in familial dysautonomia. J Neuro-ophthalmology 1997; 17: 101-102.
186. Makhoul J, Cordonnier M, Van Nechel C. Optic neuropathy in Strumpell-Lorrain disease: presentation of a clinical case and literature review. Bull Soc Belge Ophthalmol 2002; 286: 9-14.
187. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002; 40: 573-584.
188. Shoubridge EA. Cytochrome c oxidase deficiency. Am J Med Genet 2001; 106: 46-52.
189. Biousse V, Newman NJ. Neuro-ophthalmology of mitochondrial diseases. Semin Neurol. 2001; 21: 275-291.
190. Carelli V, Sadun AA. Optic neuropathy in LHON and Leigh Syndrome. Ophthalmology 2001; 108: 1172-1173.